2021
DOI: 10.5530/ijper.55.2.74
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Characterization and Pharmacological Evaluation of Biphenyl Based 4-Thiazolidinones

Abstract: Background: Biphenyl based 4-thiazolidinones are found to possess a wide range of activities resulting in their synthesis. Methods: Eight molecules (VIIa-VIIh) were profoundly synthesized using four step procedures. These 4-thiazolidinone derivatives were characterized by elemental analysis (CHN) and spectral (IR and 1 H NMR) analysis. All the compounds were evaluated for their in vitro antimicrobial activity against one Gram negative strain (Escherichia coli) and two Gram positive strains (Bacillus subtilis a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Among the series of 116a-116d, Compound 116c with chloro substituent showed the antibacterial activity against E. coli practically equivalent to trimethoprim and better than trimethoprim against Acinetobacter baumannii and Streptococcus pyogenes [123]. The biphenylbased thiazolidine-4-ones (117a-117c) showed good antimicrobial against bacterial (E. coli, S. aureus, B. subtilis) and fungal (A. niger, C. albicans) strains, except 117c that exhibited moderate effect against fungal strains [124]. The Compounds 11 and 43a (Figures 7 and 18) exhibited strong antimicrobial activity against four bacterial (E. coli, K. pneumoniae, S. aureus and B. subtilis) and three fungal (A. niger, Aspergillus oryzae and C. albicans) strains with MIC = 1.5 µg/mL.…”
Section: Antimicrobial Activitymentioning
confidence: 99%
See 1 more Smart Citation
“…Among the series of 116a-116d, Compound 116c with chloro substituent showed the antibacterial activity against E. coli practically equivalent to trimethoprim and better than trimethoprim against Acinetobacter baumannii and Streptococcus pyogenes [123]. The biphenylbased thiazolidine-4-ones (117a-117c) showed good antimicrobial against bacterial (E. coli, S. aureus, B. subtilis) and fungal (A. niger, C. albicans) strains, except 117c that exhibited moderate effect against fungal strains [124]. The Compounds 11 and 43a (Figures 7 and 18) exhibited strong antimicrobial activity against four bacterial (E. coli, K. pneumoniae, S. aureus and B. subtilis) and three fungal (A. niger, Aspergillus oryzae and C. albicans) strains with MIC = 1.5 µg/mL.…”
Section: Antimicrobial Activitymentioning
confidence: 99%
“…Among the series of 116a-116d, Compound 116c with chloro substituent showed the antibacterial activity against E. coli practically equivalent to trimethoprim and better than trimethoprim against Acinetobacter baumannii and Streptococcus pyogenes [123]. The biphenylbased thiazolidine-4-ones (117a-117c) showed good antimicrobial against bacterial (E. coli, S. aureus, B. subtilis) and fungal (A. niger, C. albicans) strains, except 117c that exhibited moderate effect against fungal strains [124]. Among the 3-amino-2-aryl/alkylthiazolidin-one derivatives, Compound 115 (Figure 50) showed higher inhibitory activity (inhibition zone -8-17 mm) than standard chloramphenicol (5-15 mm) to concentration 150 µg/mL against all tested strains (Proteus vulgaris, E. coli, K. pneumoniae, P. aeruginosa and S. aureus) [122].…”
Section: Antimicrobial Activitymentioning
confidence: 99%